Last kr247.80 DKK
Change Today 0.00 / 0.00%
Volume 1.2M
NOVOB On Other Exchanges
Symbol
Exchange
OTC US
Copenhagen
New York
Frankfurt
Frankfurt
As of 11:01 AM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Henrik Sandvad Rasmussen M.D., Ph.D.

Chief Scientific Officer and Chief Medical Officer, ZS Pharma, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 7 different industries.

55$598,168
As of Fiscal Year 2013

Background*

Dr. Henrik Sandvad Rasmussen, M.D., Ph.D. serves as CMO Consultant at Vaxin, Inc. Dr. Rasmussen has been the Chief Scientific Officer and Chief Medical Officer at ZS Pharma, Inc. since October 2012. Dr. Rasmussen serves as General Counsel, Corporate Affairs of VKR Holding A/S. Dr. Rasmussen served as the Vice President of Clinical Medical and Regulatory Affairs for Novo Nordisk A/S since February 16, 2007. Dr. Rasmussen served as Senior Vice President of Clinical Research ...

Read Full Background

Corporate Headquarters*

Novo Allé
Bagsvaerd, Capital Region of Denmark 2880

Denmark

Phone: 45 44 44 88 88
Fax: 45 44 49 05 55

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD 1992
Københavns Universitet
MD
Københavns Universitet
Bachelor's Degree
Open University Business School

Other Affiliations*

Annual Compensation*

Salary$300,000
Bonus$90,000
Total Annual Compensation$390,000

Stock Options*

All Other Compensation$34,318
Exercisable Options112,113
Unexercisable Options180,357
Total Number of Options292,470

Total Compensation*

Total Annual Cash Compensation$424,318
Total Short Term Compensation$390,000
Other Long Term Compensation$34,318
Total Calculated Compensation$598,168
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOVOB:DC kr247.80 DKK 0.00

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVO NORDISK A/S-B, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.